Stockscreener 앱 받기
1.27
0.78%
-0.01
시간 외 거래:
1.27
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam Inc. Stock Analysis and ForecastUnmatched market performance - Jammu Links News
What analysts say about HeartBeam Inc. Equity Warrant stockFree Capital Allocation Plans - Jammu Links News
Is HeartBeam Inc. a good long term investmentConsistent high-performance stocks - Jammu Links News
What analysts say about HeartBeam Inc. stockMarket-leading capital gains - Jammu Links News
HeartBeam Holds Virtual Annual Stockholders Meeting - MSN
HeartBeam elects directors and approves equity plan amendment at annual meeting - Investing.com
What makes HeartBeam Inc. Equity Warrant stock price move sharplyFree Stock Investment Discussion Area - Newser
Why HeartBeam Inc. stock attracts strong analyst attentionFree Stock Market Analysis Courses - Newser
Why HeartBeam Inc. Equity Warrant stock attracts strong analyst attentionSafety First Trading Signals - Newser
What makes HeartBeam Inc. stock price move sharplyInvestor Favorite Picks - Newser
How HeartBeam Inc. stock performs during market volatilityInstant Stock Updates - Newser
How HeartBeam Inc. Equity Warrant stock performs during market volatilityHigh Reward Risk Balanced Trading - Newser
IBN Coverage: HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection - The Globe and Mail
HeartBeam (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology - TipRanks
IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch - Yahoo Finance
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025 - Business Wire
BEAT Stock: A Comprehensive Analysis and Forecast - investchronicle.com
HeartBeam Inc. Pioneers Cable-Free 12-Lead ECG System for At-Home Cardiac Monitoring - citybuzz -
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG - citybuzz -
HeartBeam (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG - financial-news.co.uk
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results - citybuzz -
Here's Why HeartBeam (NASDAQ:BEAT) Must Use Its Cash Wisely - Yahoo Finance
HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing
Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India
HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com
HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus
HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer
HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa
Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria
HeartBeam, Inc. SEC 10-Q Report - TradingView
HeartBeam Reports First Quarter 2025 Results - Business Wire
The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail
HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance
Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com
4.17%
0.99%
자본화:
|
볼륨(24시간):